Clarus Ventures I, Llc - Net Worth and Insider Trading

Clarus Ventures I, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Clarus Ventures I, Llc owns 4 companies in total, including Oxford Immunotec Global PLC (OXFD) , Sientra Inc (SIENQ) , and Globus Medical Inc (GMED) among others .

Click here to see the complete history of Clarus Ventures I, Llc’s form 4 insider trades.

Insider Ownership Summary of Clarus Ventures I, Llc

Ticker	Comapny	Transaction Date	Type of Owner
OXFD	Oxford Immunotec Global PLC	2015-06-15	10 percent owner
SIENQ	Sientra Inc	2014-10-28	10 percent owner
GMED	Globus Medical Inc	2012-08-02	other: GP Clarus Ventures I Mngmt.
		2011-09-16	10 percent owner

Clarus Ventures I, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Clarus Ventures I, Llc Ownership Network

Ownership Network List of Clarus Ventures I, Llc

No Data

Ownership Network Relation of Clarus Ventures I, Llc

Clarus Ventures I, Llc Owned Company Details

What does Oxford Immunotec Global PLC do?

Who are the key executives at Oxford Immunotec Global PLC?

Clarus Ventures I, Llc is the 10 percent owner of Oxford Immunotec Global PLC. Other key executives at Oxford Immunotec Global PLC include director & Chief Executive Officer Peter Wrighton-smith , Chief Financial Officer Mclaughlin Matthew T E , and Chief Operating Officer Stefan C Linn .

Oxford Immunotec Global PLC (OXFD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oxford Immunotec Global PLC (OXFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oxford Immunotec Global PLC (OXFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oxford Immunotec Global PLC (OXFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oxford Immunotec Global PLC Insider Transactions

No Available Data

What does Sientra Inc do?

Who are the key executives at Sientra Inc?

Clarus Ventures I, Llc is the 10 percent owner of Sientra Inc. Other key executives at Sientra Inc include director & President and CEO Ronald Menezes , General Counsel and VP Oliver Christian Bennett , and Chief Financial Officer Andrew C Schmidt .

Sientra Inc (SIENQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sientra Inc (SIENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sientra Inc (SIENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sientra Inc (SIENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sientra Inc Insider Transactions

No Available Data

What does Globus Medical Inc do?

Who are the key executives at Globus Medical Inc?

Clarus Ventures I, Llc is the other: GP Clarus Ventures I Mngmt. of Globus Medical Inc. Other key executives at Globus Medical Inc include director & Vice President & Operations David D Davidar , SVP & General Counsel Kelly Huller , and SVP & Chief Financial Officer Keith W Pfeil .

Globus Medical Inc (GMED) Insider Trades Summary

Over the past 18 months, Clarus Ventures I, Llc made no insider transaction in Globus Medical Inc (GMED). Other recent insider transactions involving Globus Medical Inc (GMED) include a net sale of 106,750 shares made by Dan Lemaitre , a net sale of 45,000 shares made by David D Davidar , and a net sale of 11,590 shares made by Leslie V Norwalk .

In summary, during the past 3 months, insiders sold 41,000 shares of Globus Medical Inc (GMED) in total and bought 0 shares, with a net sale of 41,000 shares. During the past 18 months, 185,840 shares of Globus Medical Inc (GMED) were sold and 0 shares were bought by its insiders, resulting in a net sale of 185,840 shares.

Globus Medical Inc (GMED)'s detailed insider trading history can be found in Insider Trading Tracker table.

Globus Medical Inc Insider Transactions

No Available Data

What does Zogenix Inc do?

Who are the key executives at Zogenix Inc?

Clarus Ventures I, Llc is the 10 percent owner of Zogenix Inc. Other key executives at Zogenix Inc include EVP & CHIEF COMMERCIAL OFFICER Ashish M Sagrolikar , EVP/Chief Development Officer Gail M Farfel , and director & President and CEO Stephen J Farr .

Zogenix Inc (ZGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zogenix Inc Insider Transactions

No Available Data

Clarus Ventures I, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Clarus Ventures I, Llc. You might contact Clarus Ventures I, Llc via mailing address: 101 Main Street, Suite 1210, Cambridge Ma 02142.

Discussions on Clarus Ventures I, Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.